Cited by 14

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Liver Injury from Herbs and “Dietary Supplements”: Highlights of a Literature Review from 2015 to 2017

Teschke, Rolf, Eickhoff, Axel, Wolff, Albrecht, Xuan, Tran Dang·2018·Current Pharmacology Reports

Overview

Integrity signals

Registry

Crossref · 10.1007/s40495-018-0124-7

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 64

  1. Shahbaz O, Mahajan S, Lewis JH. Highlights of drug- and herb-induced liver injury in the literature from 2016: how best to translate new information into clinical practice? Expert Opin Drug Metab Toxicol 2017; 13(9):935–951. Available at: https://doi.org/10.1080/17425255.2017.1362391 · DOI · Paper page
  2. Sarges P, Steinberg JM, Lewis JH. Drug-induced liver injury: highlights from a review of the 2015 literature. Drug Saf. 2016;39(6):561–75. https://doi.org/10.1007/s4026401604278 . · DOI
  3. Teschke R, Andrade RJ. Editorial. Special issue “drug, herb, and dietary supplement hepatotoxicity”. Int J Mol Sci. 2016;17(9):1488. https://doi.org/10.3390/ijms17091488 . Available at: http://www.mdpi.com/journal/ijms/special_issues/Hepatotoxicity . Accessed 22.10.17. · DOI · Paper page
  4. Danan G, Teschke R. RUCAM in drug and herb induced liver injury: the update. Int J Mol Sci. 2016;17(1):14. https://doi.org/10.3390/ijms17010014 . · DOI · Paper page
  5. Frenzel C, Teschke R. Herbal hepatotoxicity: clinical characteristics and listing compilation. Int J Mol Sci. 2016;17(5):588. https://doi.org/10.3390/ijms17050588 . · DOI · Paper page
  6. Valdivia-Correa B, Gómez-Gutiérrez C, Uribe M, Méndez-Sánchez N. Herbal medicine in Mexico: a cause of hepatotoxicity. A critical review. Int J Mol Sci. 2016;17(2):235. https://doi.org/10.3390/ijms17020235 . · DOI
  7. Douros A, Bronder E, Andersohn F, Klimpel A, Kreutz R, Garbe E, et al. Herb-induced liver injury in the Berlin Case-Control Surveillance Study. Int J Mol Sci. 2016;17(1):114. https://doi.org/10.3390/ijms17010114 . · DOI
  8. Pantano F, Tittarelli R, Mannocchi G, Zaami S, Ricci S, Giorgetti R, et al. Hepatotoxicity induced by “the 3Ks”: Kava, Kratom and Khat. Int J Mol Sci. 2016;17(4):580. https://doi.org/10.3390/ijms17040580 . · DOI
  9. Teschke R, Eickhoff A. The Honolulu liver disease cluster at the medical center: its mysteries and challenges. Int J Mol Sci. 2016;17(4):476. https://doi.org/10.3390/ijms17040476 . · DOI · Paper page
  10. Avigan MI, Mozersky RP, Seeff LB. Scientific and regulatory perspectives in herbal and dietary supplement associated hepatotoxicity in the United States. Int J Mol Sci. 2016;17(3):331. https://doi.org/10.3390/ijms17030331 . · DOI
  11. Dakhiya Y, Hussien D, Fridman E, Kiflawi M, Green R. Correlations between circadian rhythms and growth in challenging environments. Plant Physiol. 2017;173(3):1724–34. https://doi.org/10.1104/pp.17.00057 . · DOI · Paper page
  12. Xuan TD, Khanh TD, Khang DT, Quan NT, Elzaawely AA. Changes in chemical composition, total phenolics and antioxidant activity of Alpinia (Alpinia zerumbet) leaves exposed to UV. Int Lett Nat Sci. 2016;55:25–34. https://doi.org/10.18052/www.scipress.com/ILNS.55.25 . · DOI
  13. Xuan TD, Teschke R. Dihydro-5,6-dehydrokavain (DDK) from Alpinia zerumbet: its isolation, synthesis, and characterization. Molecules. 2015;20(9):16306–19. https://doi.org/10.3390/molecules200916306 . · DOI
  14. Teschke R, Schwarzenboeck A, Frenzel C, Schulze J, Eickhoff A, Wolff A. The mystery of the Hawaii liver disease cluster in summer 2013: a pragmatic and clinical approach to solve the problem. Ann Hepatol. 2016;15:91–119. Available at: http://www.annalsofhepatology.com.mx/revista/numeros/2016/HP161-12-Mystery%20(web)%20(FF_041215V)_PROTEGIDO%20(1).pdf . Accessed 22.10.2017 · DOI · Paper page
  15. Calitz C, du Plessis L, Gouws C, Steyn D, Steenekamp J, Muller C, et al. Herbal hepatotoxicity: current status, examples, and challenges. Expert Opin Drug Metab Toxicol. 2015;11(10):1551–65. https://doi.org/10.1517/17425255.2015.1064110 . · DOI
  16. Brown A. Liver toxicity related to herbs and dietary supplements: online table of case reports. Part 2 of 5 series. Food Chem Toxicol. 2017;107(Pt A):472–501. https://doi.org/10.1016/j.fct.2016.07.001 . · DOI · Paper page
  17. Jing J, Teschke R. Traditional Chinese medicine (TCM) and herb induced liver injury: comparison with drug induced liver injury. J Clin Transl Hepatol. 2018;6(1):1–12. https://doi.org/10.14218/JCTH.2017.00033 . · DOI
  18. Teschke R, Wolff A, Frenzel C, Eickhoff A, Schulze J. Herbal traditional Chinese medicine and its evidence base in gastrointestinal disorders. World J Gastroenterol. 2015;21(15):4466–90. https://doi.org/10.3748/wjg.v21.i15.4466 . · DOI
  19. Teschke R, Larrey D, Melchart D, Danan G. Traditional Chinese medicine (TCM) and herbal hepatotoxicity: RUCAM and the role of novel diagnostic biomarkers such as microRNAs. Medicines. 2016;3(3):18. https://doi.org/10.3390/medicines3030018 . · DOI · Paper page
  20. Wang R, Han D, Sun M, Teschke R, Yang SS, Mendez-Sanchez N, et al. Efficacy and safety of integration of traditional and Western medicine for the treatment of spontaneous bacterial peritonitis in liver cirrhosis: a systematic review. AME Med J. 2017;2:138. https://doi.org/10.21037/amj.2017.08.10 . · DOI
  21. Teschke R, Eickhoff A. Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps. Front Pharmacol. 2015;6:72. · DOI · Paper page
  22. Melchart D, Hager S, Albrecht S, Dai J, Weidenhammer W, Teschke R. Herbal Traditional Chinese Medicine and suspected liver injury: a prospective study. World J Hepatol. 2017;18(9):1141–57. https://doi.org/10.4254/wjh.v9.i29.1141 . · DOI · Paper page
  23. Teschke R, Danan G. Causality assessment in pharmacovigilance for herbal medicines. In: Barnes J, editor. Pharmacovigilance of herbal medicines: reflections, solutions and future perspectives. Berlin: Springer (Adis Books); 2017. in press.
  24. Teschke R, Schulze J, Eickhoff A, Wolff A, Frenzel C. Mysterious Hawaii liver disease case—naproxen overdose as cause rather than OxyELITE pro? J Liver Clin Res. 2015;2(2):1013. Available at: http://www.jscimedcentral.com/Liver/liver-2-1013.pdf . Accessed 20.10.17
  25. Teschke R, Eickhoff A, Schulze J, Wolff A, Frenzel C, Melchart D. Petadolex®, a herbal extract for migraine prophylaxis with spontaneous case reports of disputed liver injury: robust causality evaluation by RUCAM, the Roussel Uclaf Causality Assessment Method. Eur J Pharm Med Res. 2016;3(12):154–77.
  26. Liu WJH. Feature article. What has been overlooked on study of Chinese Materia Medica in the West? Chin J Integr Med. 2015;21:483–99. · DOI
  27. Zambrone FAD, Corrêa CL, Sampaio do Amaral LM. A critical analysis of the hepatotoxicity cases described in the literature related to Herbalife products. Braz J Pharm Sci. 2015;51:785–96. Available at: https://doi.org/10.1590/S1984-82502015000400004 . · DOI
  28. Cha JY, Khaleda L, Park HJ, Kim WY. A chaperone surveillance system in plant circadian rhythms. BMB Rep. 2017;50(5):235–6. https://doi.org/10.5483/BMBRep.2017.50.5.064 . · DOI
  29. Elzaawely AA, Xuan TD, Tawata S. Changes in essential oils, kava pyrones and total phenolics of Alpinia zerumbet (Pers.) B. L. Burtt. & R.M. Sm. leaves exposed to copper sulphate. Environ Exp Bot. 2007b;59(3):347–53. https://doi.org/10.1016/j.envexpbot.2006.04.007 . · DOI · Paper page
  30. Tong K, Li ZL, Sun X, Yan S, Jiang MJ, Deng MS, et al. Metabolomics approach reveals annual metabolic variation in roots of Cyathula officinalis Kuan based on gas chromatography-mass spectrum. Chin Med. 2017;12(1):12. https://doi.org/10.1186/s13020-017-0133-1 . · DOI · Paper page
  31. Lin L, Li H, Lin H, Zhang M, Qu C, Yan L, et al. A new perspective on liver injury by traditional Chinese herbs such as Polygonum multiflorum: The geographical area of harvest as an important contributory factor. Front Pharmacol. 2017. Available at: https://doi.org/10.3389/fphar.2017.00349 · DOI · Paper page
  32. Kuchta K, Schmidt M, Nahrstedt A. German Kava ban lifted by court: the alleged hepatotoxicity of Kava (Piper methysticum) as a case of ill-defined herbal drug identity, lacking quality control, and misguided regulatory politics. Planta Med. 2015;81(18):1647–53. https://doi.org/10.1055/s-0035-1558295 . · DOI
  33. Savage K, Stough C, Byrne GJ, Scholey A, Bousman C, Murphy J, et al. Kava for the Treatment of Generalised Anxiety Disorder (K-GAD): study protocol for a randomized controlled trial. Trials. 2015;16:493. Available at: http://www.trialsjournal.com/content/16/1/493/about · DOI
  34. Hamre HJ, Glockmann A, Heckenbach K, Matthes H. Use and safety of anthroposophic medicinal products: an analysis of 44,662 patients from the EvaMed Pharmacovigilance Network. Drugs Real World Outcomes. 2017; https://doi.org/10.1007/s40801-017-0118-5 . · DOI
  35. Calahan J, Howard D, Almalki A, Gupta MP, Calderón AI. Chemical adulterants in herbal medicinal products: a review. Planta Med. 2016;82(06):505–15. https://doi.org/10.1055/s-0042-103495 . · DOI
  36. Gao H, Ruan JQ, Chen J, Li N, Ke CQ, Ye Y, et al. Blood pyrrole-protein adducts as diagnostic and prognostic index in pyrrolizidine alkaloid-hepatic sinusoidal obstruction syndrome. Drug Des Dev Ther. 2015;9:4861–8. · DOI · Paper page
  37. Melchart D, Hager S, Dai J, Weidenhammer W. Quality control and complication screening programme of Chinese medicinal drugs at the first German hospital of Traditional Chinese Medicine—a retrospective analysis. Forsch Komplementärmed. 2016;23(2):21–8. https://doi.org/10.1159/000444983 . · DOI
  38. Zhang P, Ye Y, Yang X, Jiao Y. Systematic review on Chinese herbal medicine induced liver injury. Evid Based Complement Alternat Med. 2016:3560812. https://doi.org/10.1155/2016/3560812 . · DOI · Paper page
  39. Teschke R, Zhang L, Long H, Schwarzenboeck A, Schmidt-Taenzer W, Genthner A, et al. Traditional Chinese Medicine and herbal hepatotoxicity: a tabular compilation of reported cases. Ann Hepatol. 2015;14:7–19. · DOI
  40. Cho JH, Oh DS, Hong SH, Ko H, Lee NH, Park SE, et al. A nationwide study of the incidence rate of herb-induced liver injury in Korea. Arch Toxicol. 2017; https://doi.org/10.1007/s00204-017-2007-9 . · DOI · Paper page
  41. Vega M, Verma M, Beswick D, Bey S, Hossack J, Merriman N, et al. The incidence of drug- and herbal and dietary supplement-induced liver injury: preliminary findings from gastroenterologist-based surveillance in the population of the State of Delaware. Drug Saf. 2017;40(9):783–7. https://doi.org/10.1007/s40264-017-0547-9 . · DOI · Paper page
  42. Teschke R, Eickhoff A. Suspected liver injury and the dilemma of causality. Dig Dis Sci. 2017;62(4):1095–8. https://doi.org/10.1007/s10620-016-4442-5 . · DOI
  43. Teschke R, Editorial DG. Drug-induced liver injury, mortality, and liver transplantation: is it reasonable to use a global introspection causality assessment? AME Med J. 2017; https://doi.org/10.21037/amj.2017.9.05 . · DOI
  44. Teschke R, Eickhoff A, Schwarzenboeck A, Schmidt-Taenzer W, Genthner A, Frenzel C, et al. Clinical review: Herbal hepatotoxicity and the call for systematic data documentation of individual cases. J Liver Clin Res. 2015;2:1008. Available at: http://www.jscimedcentral.com/Liver/liver-2-1008.pdf
  45. Teschke R, Schulze J, Eickhoff A, Danan G. Drug induced liver injury: can biomarkers assist RUCAM in causality assessment? Int J Mol Sci. 2017;18(4):803. https://doi.org/10.3390/ijms18040803 . · DOI
  46. Zhu Y, Niu M, Chen J, Zou ZS, Ma ZJ, Liu SH, et al. Comparison between Chinese herbal medicine and Western medicine-induced liver injury of 1985 patients. J Gastroenterol Hepatol. 2016;31(8):1476–82. https://doi.org/10.1111/jgh.13323 . · DOI · Paper page
  47. Mazzanti G, Di Soto A, Vitalone A. Hepatotoxicity of green tea: an update. Arch Toxicol. 2015;89(8):1175–91. https://doi.org/10.1007/s00204-015-1521-x . · DOI · Paper page
  48. Lu RJ, Zhang Y, Tang FL, Zheng ZW, Fan ZD, Zhu SM, et al. Clinical characteristics of drug-induced liver injury and related risk factors. Exp Ther Med. 2016;12(4):2606–16. https://doi.org/10.3892/etm.2016.3627 . · DOI
  49. Teschke R, Danan G. Causality assessment methods in drug-induced liver injury. In: Drug-induced liver toxicity. Minjun Chen and Yvonne Will. Methods in pharmacology and toxicology/Y. James Kang & David C. Casey. Springer Protocols, Springer, Berlin, 2018, in press.
  50. DCH T, Ng PSL, Tan SH, Lim AT, DSL T, Chan SY, et al. Drug-induced liver injury associated with complementary and alternative medicine: a review of adverse event reports in an Asian community from 2009 to 2014. BMC Complement Altern Med. 2016;16(1):192. https://doi.org/10.1186/s12906-016-1168z . · DOI · Paper page
  51. Lee WJ, Kim HW, Son CG. Systematic review on herb induced liver injury in Korea. Food Chem Toxicol. 2015;84:47–54. https://doi.org/10.1016/j.fct.2015.06.004 . · DOI · Paper page
  52. Yu YC, Mao YM, Chen CW, Chen JJ, Chen J, Cong WM, et al. CSH guidelines for the diagnosis and treatment of drug-induced liver injury. Hepatol Int. 2017;11(3):221–41. https://doi.org/10.1007/s12072-017-9793-2 . · DOI · Paper page
  53. Wang J, Ma Z, Niu M, Zhu Y, Liang Q, Zhao Y, et al. Evidence chain-based causality identification in herb-induced liver injury: exemplification of a well-known liver-restorative herb Polygonum multiflorum. Front Med. 2015;9(4):457–67. https://doi.org/10.1007/s11684-015-0417-8 . · DOI · Paper page
  54. Woo HJ, Kim HY, Choi ES, Cho YH, Kim Y, Lee JH, et al. Drug-induced liver injury: a 2-year retrospective study of 1169 hospitalized patients in a single medical center. Phytomedicine. 2015;22(13):1201–5. https://doi.org/10.1016/j.phymed.2015.10.002 . · DOI · Paper page
  55. Hayashi PH, Rockey D, Fontana RJ, Tillmann HL, Kaplowitz N, Barnhart H, et al. Death and liver transplantation within two years of onset of drug-induced liver injury. Hepatology. 2017, in press; https://doi.org/10.1002/hep.29283 . · DOI · Paper page
  56. Navarro VJ, Khan I, Björnsson E, Seeff LB, Serrano J, Hoofnagle JH. Liver injury from herbal and dietary supplements. Hepatology. 2017;65(1):1363–73. https://doi.org/10.1002/hep.28813 . · DOI
  57. Wong LL, Lacar L, Roytman M, Orloff SL. Urgent liver transplantation for dietary supplements: an under-recognized problem. Transplant Proc. 2017;49(2):322–5. https://doi.org/10.1016/j.transproceed.2016.11.041 . · DOI
  58. Cholankeril G, Wong RJ, Hu M, Perumpail RB, Yoo ER, Puri P, et al. Liver transplantation for nonalcoholic steatohepatitis in the US: temporal trends and outcomes. Dig Dis Sci. 2017;62(10):2915–22. https://doi.org/10.1007/s10620-017-4684-x . · DOI
  59. Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wimmer M. Fatty liver disease—meta-analytic assessment of prevalence assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73–84. https://doi.org/10.1002/hep.28431 . · DOI · Paper page
  60. Hayashi PH. Drug-induced liver injury network causality assessment: criteria and experience in the United States. Int J Mol Sci. 2016;17(2):201. https://doi.org/10.3390/ijms17020201 . · DOI
  61. Teschke R, Xuan TD. Viewpoint: a contributory role of Shell ginger (Alpinia zerumbet) and human longevity of Okinawa in Japan? Nutrients. 2018;10:166. https://doi.org/10.3390/nu10020166 . · DOI
  62. Teschke R, Danan G. Review article: Diagnosis and management of drug-induced liver injury (DILI) in patients with pre-existing liver disease. Drug Saf. 2016;39(8):729–44. https://doi.org/10.1007/s40264-016-0423-z . · DOI
  63. Teschke R, Danan G. Drug-induced liver injury: is chronic liver disease a risk factor and a clinical issue? Expert Opin Drug Metab Toxicol. 2017;13(4):425–38. https://doi.org/10.1080/17425255.2017.1252749 . · DOI
  64. Ogden CL, Carroll MD, Fryar CD, Flegal KM. Prevalence of obesity among adults and youth: US, 2011–2014. NCHS Data Brief. 2015;219:1–8.

Cited by

Sorted by citations

Metadata

Authors
Teschke, R., Eickhoff, A., Wolff, A., & Xuan, T. D.
Venue
Current Pharmacology Reports
Published
2018-02-14
Volume
4
Issue
2
Pages
120-131
ISSN
2198-641X
Cited by
14
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review